Sie befinden Sich hier: Start > Veranstaltungen > Pharma, Kosmetik, Medizin

Marketing Authorisation in Asia

China, Hong Kong, Indonesien, Singapur, Thailand, Korea, Malaysia, Philippinen, Vietnam, Taiwan

Update on the regulatory framework in Asia with a focus on China, Hong Kong, Indonesia, Korea, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam.

Die Themen

  • Current regulatory framework in the Asian countries
  • Marketing authorisation for NCEs and generics
  • Submission of variations and renewals
  • Communication with the authorities - meetings?
  • ASEAN: Harmonisation of the Asian drug market?

Ziele

Two experts in drug regulatory affairs will give you a thorough update on the current regulatory framework of the various Asian countries.

  • What kind of (study) data do you need when applying for a marketing authorisation?
  • What are the challenges when applying for an NCE or a Generics marketing authorisation?
  • How can you communicate with the authorities?
  • How can you assure the maintenance of a granted marketing authorisation?

These and many more questions will be addressed during the two seminar days. Will you join us?

Teilnehmerkreis

This seminar will be of benefit to all those working in the pharmaceutical industry and interested in marketing pharmaceuticals in Asia. Especially those working in regulatory affairs and business development will profit from the seminar.

Ihre Referenten

Dr. Alan A. Chalmers

Dr. Alan A. Chalmers

Pharma International, Innovation Centre, SWITZERLAND

Dr. Mónica Dressler-Meyer

Dr. Mónica Dressler-Meyer

Consultant for Regulatory Affairs, Binningen, SWITZERLAND

Nummer: 1210231
Datum:
17.10.2012 - 18.10.2012
Ort:
Frankfurt
Preis
1590,- €
zzgl. MwSt.
Jetzt buchen!

Ihr Ansprechpartner

Dr. Henriette Wolf-Klein

Dr. Henriette Wolf-Klein

Bereichsleiterin Pharma

+49 6221 500-680

> E-Mail senden



> Inhouse-Angebot anfordern